Guj. Inject(Ker)

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE659F01022
  • NSEID:
  • BSEID: 524238
INR
9.44
-0.03 (-0.32%)
BSENSE

Oct 09

BSE+NSE Vol: 3.91 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 90.70% vs 229.04% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 114.66% vs 2,296.55% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -86.67% vs 237.31% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 78.34% vs 1,129.05% in Mar 2025

Compare Profit and Loss Results of Guj. Inject(Ker)
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
36.00
30.00
6.00
20.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
36.00
30.00
6.00
20.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-8.00
8.00
100.00%
Raw Materials Consumed
33.00
14.00
19.00
135.71%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
0.00
5.00
-5.00
-100.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
2.00
-2.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
34.00
20.00
14.00
70.00%
Operating Profit (PBDIT) excl Other Income
2.00
10.00
-8.00
-80.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
2.00
12.00
-10.00
-83.33%
Interest
0.00
4.00
-4.00
-100.00%
Profit before Depriciation and Tax
2.00
7.00
-5.00
-71.43%
Depreciation
0.00
2.00
-2.00
-100.00%
Profit Before Taxation & Exceptional Items
2.00
4.00
-2.00
-50.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2.00
4.00
-2.00
-50.00%
Provision for Tax
0.00
1.00
-1.00
-100.00%
Profit After Tax
1.00
3.00
-2.00
-66.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-8.00
35.00
-43.00
-122.86%
Profit Available for appropriations
-6.00
39.00
-45.00
-115.38%
Appropriations
-6.00
39.00
-45.00
-115.38%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.24
5.67
-4.43
-78.13%
Profit And Loss - Net Sales
Net Sales 36.32 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 90.70% vs 229.04% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.31 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 114.66% vs 2,296.55% in Mar 2025

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -86.67% vs 237.31% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 1.81 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 78.34% vs 1,129.05% in Mar 2025